CLINICAL_TRIALS ClinicalTrials.gov record update

Safety/Efficacy of Intranasally-Administered Bioactive Factors Produced by Autologous M2 Macrophages in Patients With Organic Brain Syndrome

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT02957123
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:38:18.142078+00:00
Published At: 2021-02-18T00:00:00+00:00
Record Updated At: 2021-02-18
Results Posted At: 2021-02-18
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Organic Brain Syndrome, Nonpsychotic", "Neurocognitive Disorders", "Mental Disorder, Organic", "Delirium, Dementia, Amnestic, Cognitive Disorders", "Nonpsychotic Organic Brain Syndrome", "Organic Mental Disorder", "Encephalopathy, Post-Traumatic, Chronic", "Encephalopathy, Ischemic", "Brain Ischemia"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2021-02-18"
protocolSection.identificationModule.nctId: "NCT02957123"
protocolSection.identificationModule.officialTitle: "Safety/Efficacy of Intranasally-Administered Bioactive Factors Produced by Autologous M2 Macrophages in Patients With Organic Brain Syndrome"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE1", "PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: "2021-02-18"

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.